​​​

​Department of Neuroanaesthesiology provides anaesthesia and surgical assistance as well as intensive care for patients undergoing surgery and treatments for neurological diseases.​​​​

Scope of Care

  • Anaesthesia and perioperative care for neurosurgical patients.
  • Intensive care for postoperative neurosurgical patients, all ages.
  • Recovery care for postop​erative neurosurgical patients, all ages.
  • Recovery care for MRI-anaesthesia patients.
  • Intensive care for neurosurgical patients.
  • Intensive care for patients with neurological disease and respiratory affection.

Supplementary

  • Implementation and development of PDM in Intensive Care Unit.
  • Specific support programmes for patients and groups of relatives in Intensive Care Unit.
  • Training programme for Junior Doctors in anaesthesiology.
  • Training programme for medical students.
  • Qualification development projects in all three departments.
  • VIPS in all three departments.

Identified High Risk Areas w​ith underlined clinical guidelines

Operating Theatre/ anaesthesia:​
  • Anaesthesia for patients with subarachnoidal haemorrhagia (aneurysm).
  • Anaesthesia for children suffering from posterior cerebral tumor.
Neurointensive Care Unit:​
  • Neurointensive treatment of patients suffering from subarachnoidal haemorrhagia.
  • Neurointensive treatment of the neurotraumatised patients.

List quality-improvement projects/initiatives

  • Optimising of children admissions in Intensive Care Unit.
  • Psychological environment: GRUS in Intensive Care Unit.
  • Implementation of surgical and anaesthesiological activities in the MR-scanner and in the operating theatre.
  • Implementation of booking procedures in the operating theatre and anaesthesiology.​

Niels Risør Hammer
Head of Department
E-mail: niels.risoer.hammer@regionh.dk


René Richard Andersen
Head nurse

Copenhagen Neuroanaesth​esiology and Neurointensive Care Research Group​​

​​​Department of Neuroanaesthesiology
Section 6011
Inge Lehmanns Vej 6
2100 København Ø
Denmark​

 News from Rigshospitalet

CoPPO 10th Anniversary Symposium – save the date

​8 March 2024 we will host a symposium celebrating 10 years with the Copenhagen Prospective Personalized Oncology study. Bridging genomic research and clinical oncology.

Research projects presented at the Molecular targets and cancer therapeutics congress

​Three research projects were elected for poster presentation at the Molecular targets and cancer therapeutics congress 2023 in Boston, USA. The studies are highly relevant for our work at the Phase 1 Unit and the use of genomic profiling in cancer patients. The studies were conducted and presented by two PhD students at the Phase 1 unit, Rigshospitalet, Denmark: Laila Belcaid and Cecilie Iden.

Pioneer in Alzheimer's disease receives our international research award

​This year, Rigshospitalet's International KFJ Award goes to Swedish Professor Kaj Blennow, who is recognized as a global leader in the development of biomarkers for the diagnosis of Alzheimer's disease.​

Newly discovered risk genes for migraine may lead to more targeted treatment

​Researchers have discovered new migraine genes which contain new and more accurate information about the condition of the individual patient. This may lead to more targeted treatment.

Largest ever mapping of long-term symptoms of COVID-19

​Patients most severely affected by COVID-19 who had to spend many days bedridden have the most severe long-term post-infection problems. This is documented in a new study, in which researchers have monitored people for more than two years after they were infected with COVID-19.

The TEMPLE study presented at ESMO 2023

​Last week the TEMPLE study (Thiopurine Enhanced Mutations for PD-1/Ligand-1 Efficacy) was presented at the European Society for Medical Oncology (ESMO) 2023 annual conference in Madrid. The trial-in-progress poster was presented by Christine Federspiel Secher, MD, PhD-student.

Poster presenting therapeutic implications in squamous cell carcinomas presented at ESMO

​The research project “Mutational landscape and therapeutic implications in squamous cell carcinomas” was elected for poster presentation at the European Society for Medical Oncology (ESMO) congress 2023 in Madrid, Spain. The study was conducted by Laila Belcaid, MD, PhD student at the Phase 1 unit, Rigshospitalet, Denmark.

New recommendation with the purpose of strengthening clinical research in Denmark

​A working committee has formulated recommendations on how Denmark can enhance global competition and remain an attractive collaborator in clinical research.

New research sheds light on genetics of placenta growth

​Study identifies 40 variations in the genetic code linked to placenta growth and points at link to health risks for mother and child.

Danish corona research could improve vaccination techniques

​Ground-breaking research from Copenhagen University Hospital – Rigshospitalet and Herlev and Gentofte Hospital has shed new light on the immune system’s complex struggle against the coronavirus.